We are live on ! Find out more
ELAN icon

Elanco Animal Health

452 hedge funds and large institutions have $14.9B invested in Elanco Animal Health in 2021 Q3 according to their latest regulatory filings, with 52 funds opening new positions, 175 increasing their positions, 141 reducing their positions, and 74 closing their positions.

New
Increased
Maintained
Reduced
Closed

69% more call options, than puts

Call options by funds: $57.9M | Put options by funds: $34.2M

24% more repeat investments, than reductions

Existing positions increased: 175 | Existing positions reduced: 141

0% more funds holding in top 10

Funds holding in top 10: 1111 (0)

0.08% less ownership

Funds ownership: 99.07%98.99% (-0.08%)

5% less funds holding

Funds holding: 478452 (-26)

8% less capital invested

Capital invested by funds: $16.2B → $14.9B (-$1.31B)

30% less first-time investments, than exits

New positions opened: 52 | Existing positions closed: 74

Holders
452
Holders Change
-26
Holders Change %
-5.44%
% of All Funds
7.91%
Holding in Top 10
11
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.19%
New
52
Increased
175
Reduced
141
Closed
74
Calls
$57.9M
Puts
$34.2M
Net Calls
+$23.7M
Net Calls Change
+$26.1M
Name Holding Trade Value Shares
Change
Change in
Stake
TC
251
TownSquare Capital
Utah
$897K +$555K +16,538 +143%
DAM
252
Deltec Asset Management
New York
$895K +$941K +28,051 New
CCP
253
Corient Capital Partners
California
$889K -$40.8K -1,216 -4%
CSS
254
Cubist Systematic Strategies
Connecticut
$838K -$16.8M -501,329 -95%
MIH
255
Meitav Investment House
Israel
$835K -$122K -3,631 -12%
Simplex Trading
256
Simplex Trading
Illinois
$833K -$14.4K -429 -2%
American Century Companies
257
American Century Companies
Missouri
$828K -$170M -5,061,247 -99%
NFGCM
258
Norman Fields Gottscho Capital Management
New York
$818K
SSWM
259
Smith Salley Wealth Management
North Carolina
$810K +$69.8K +2,079 +9%
Nordea Investment Management
260
Nordea Investment Management
Sweden
$809K
BCM
261
Bayesian Capital Management
New York
$801K +$843K +25,122 New
AC
262
Alexandria Capital
Virginia
$783K
BCV
263
Banque Cantonale Vaudoise
Switzerland
$776K +$563K +16,786 +224%
ECM
264
Estabrook Capital Management
New York
$751K
ACM
265
AlphaCrest Capital Management
New York
$741K +$401K +11,950 +106%
Rafferty Asset Management
266
Rafferty Asset Management
New York
$732K +$269K +8,019 +54%
SIC
267
SFE Investment Counsel
California
$725K -$8.39K -250 -1%
CS
268
Candriam SCA
Luxembourg
$717K
SMDAM
269
Sumitomo Mitsui DS Asset Management
Japan
$709K -$5.7K -170 -0.8%
PAM
270
Panagora Asset Management
Massachusetts
$703K
JCM
271
Jacobi Capital Management
Pennsylvania
$689K -$19.1K -568 -3%
CIBC Asset Management
272
CIBC Asset Management
Ontario, Canada
$663K +$103K +3,062 +17%
DC
273
Davenport & Co
Virginia
$657K +$28.5K +849 +4%
WBC
274
Westpac Banking Corp
Australia
$657K -$714K -21,288 -51%
Schroder Investment Management Group
275
Schroder Investment Management Group
United Kingdom
$624K -$194K -5,774 -23%

ELAN Hedge Fund Activity: Q3 2021 in Review

452 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Elanco Animal Health (ELAN) for Q3 2021, worth a combined $14.9B — down 8.1% from $16.2B a quarter earlier.

Sellers outnumbered buyers: 74 funds closed out of ELAN and 52 opened new positions — a net loss of 22 holders — while 141 trimmed existing stakes and 175 added.

The largest buyer was Franklin Resources, adding an estimated $160M. The largest seller was Janus Henderson Group, cutting an estimated $236M.

  • 452 institutional investors held Elanco Animal Health (ELAN) as of Q3 2021, down from 478 in Q2 2021.
  • Funds reported $14.9B of Elanco Animal Health stock for Q3 2021, down 8.1% quarter-over-quarter.
  • 52 funds opened new Elanco Animal Health positions in Q3 2021 and 74 closed out, a net change of -22 holders.
  • The largest Elanco Animal Health buyer in Q3 2021 was Franklin Resources, an estimated $160M added.
  • The largest Elanco Animal Health seller in Q3 2021 was Janus Henderson Group, an estimated $236M sold.

Based on aggregated 13F filings for Q3 2021.